Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. [electronic resource]
Producer: 20051215Description: 1051-9 p. digitalISSN:- 0041-1337
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- pharmacology
- Chemokines -- genetics
- Creatine -- blood
- Female
- Graft Rejection -- metabolism
- Guanidines -- pharmacology
- Humans
- Immunosuppressive Agents -- pharmacology
- Kidney -- cytology
- Kidney Transplantation -- immunology
- Lymph Nodes -- cytology
- Lymphocyte Count
- Lymphocyte Depletion
- Male
- Middle Aged
- T-Lymphocytes -- drug effects
- Transcription, Genetic
- Transplantation Tolerance -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.